Emilia García-Menor MD, Fátima García-Marín MD, Raquel Vecino-López MD, P., Gloria Horcajo-Martínez MD, María-José de Ibarrondo Gu, Pedro Gómez-González MD, . . . Concepción Nieto-Magro MD, P. (2016). A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children. SAGE Publishing.
Chicago Style (17th ed.) CitationEmilia García-Menor MD, Fátima García-Marín MD, PhD Raquel Vecino-López MD, Gloria Horcajo-Martínez MD, María-José de Ibarrondo Gu, Pedro Gómez-González MD, Syra Velasco-Ortega Pharm, BSND Javier Suárez-Almarza Pharm, and PhD Concepción Nieto-Magro MD. A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children. SAGE Publishing, 2016.
MLA (9th ed.) CitationEmilia García-Menor MD, et al. A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Additional Benefit of a Multistrain Synbiotic (Prodefen®) in the Clinical Management of Acute Viral Diarrhea in Children. SAGE Publishing, 2016.